CL
AMED

CSS LLC’s Amedisys AMED Stock Holding History

CSS LLC’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,200
Closed -$204K – 972
2025
Q1 		$204K Hold
2,200
– – 0.01% 707
2024
Q4 		$200K Buy
+2,200
New +$202K 0.01% 775

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

CSS LLC's AMED Position: Q4 2024 in Review

CSS LLC sold out of Amedisys (AMED) in Q4 2024, closing a stake of 12,290 shares — an estimated $1.13M sold.

CSS LLC first reported a position in AMED in Q1 2024 and held it in 3 quarters. The position peaked at $1.63M in Q1 2024. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • CSS LLC reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • CSS LLC sold 12,290 Amedisys shares in Q4 2024, an estimated $1.13M.
  • CSS LLC first reported a position in Amedisys in Q1 2024 and held it in 3 quarters.
  • CSS LLC's Amedisys position peaked at $1.63M in Q1 2024.
  • 290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on CSS LLC's 13F filing for Q4 2024, filed 18 Feb 2025.